tiprankstipranks
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market

Champions Oncology (CSBR) Income Statement

Compare
134 Followers

Champions Oncology Income Statement

Last quarter (Q2 2025), Champions Oncology's total revenue was $13.49M, an increase of 16.56% from the same quarter last year. In Q2, Champions Oncology's net income was $728.00K. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 50.16M$ 53.87M$ 49.11M$ 41.04M$ 32.12M
Gross Profit
$ 20.75M$ 24.34M$ 25.48M$ 19.57M$ 15.24M
Operating Expenses
$ 28.11M$ 28.79M$ 24.87M$ 19.23M$ 16.71M
Depreciation and Amortization
$ 1.87M$ 3.20M$ 2.41M$ 1.58M$ 1.23M
EBITDA
$ -5.05M$ -2.07M$ 2.23M$ 366.00K$ -735.00K
Operating Income
$ -7.36M$ -4.45M$ 607.00K$ 338.00K$ -1.47M
Other Income/Expenses
$ 48.00K$ -11.00K$ -24.00K$ 71.00K$ -495.00K
Pretax Income
$ -7.31M$ -5.27M$ 583.00K$ 409.00K$ -1.84M
Net Income
$ -7.28M$ -5.33M$ 548.00K$ 362.00K$ -1.98M
Per Share Metrics
Basic EPS
$ -0.54$ -0.39$ 0.04$ 0.03$ -0.17
Diluted EPS
$ -0.54$ -0.39$ 0.04$ 0.02$ -0.17
Weighted Average Shares Outstanding
13.55M 13.54M 13.20M 13.14M 11.84M
Weighted Average Shares Outstanding (Diluted)
13.55M 13.54M 14.16M 14.57M 11.84M
Currency in USD

Champions Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis